Company Filing History:
Years Active: 1993-1995
Title: The Innovations of William A. Hanlon
Introduction
William A. Hanlon is a notable inventor based in Lebanon, NJ (US). He has made significant contributions to the field of medical research, particularly in the development of assays for evaluating the inhibition of polymorphonuclear leukocyte elastase. His work has implications for treating various anti-inflammatory and antidegenerative diseases.
Latest Patents
William A. Hanlon holds 2 patents. His latest patents include an assay for evaluating inhibition of polymorphonuclear leukocyte elastase by N-substituted azetidinones. This class of inhibitors is known for its therapeutic potential in treating a wide variety of diseases. The assay he developed measures the hydrolysis of the inhibitor-enzyme complex, which is crucial for determining appropriate dosage and assessing treatment effectiveness.
Career Highlights
Hanlon is associated with Merck & Co., Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in clinical methodologies and therapeutic strategies.
Collaborations
Some of his notable coworkers include John L. Humes and Wilson B. Knight. Their collaborative efforts have further enhanced the research and development initiatives within their field.
Conclusion
William A. Hanlon's contributions to medical research and his innovative patents highlight his role as a significant inventor in the industry. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in healthcare.